Helse Bergen HF 983 974 724 Postboks 1400 Bergen 5021 Åshild Fløisand +47 55301045 ashild.floisand@steenstrup.no https://helse-bergen.no/ Mammography equipment (re: TOBE-study). HB040917 Helse Bergen intends to procure 2 mammography screening apparatuses and three associated work stations from GE Healthcare Norge AS (‘GE’). The procured apparatuses are partial replacements for equipment procured from GE in a former regular procurement process (MTU/2014/PROJECT 000727/Mammografiapparatur for the Breast Diagnostic Centre in Bergen). The need for the replacements is caused by the tomosynthesis-study conducted by Helse Bergen (the TOBE-study), which is based on GE screening apparatuses. The study is technically dependent on further use of GE products. The contract is dependant on the funding from the Cancer Association/Research Council of Norway for the continuation of the study. This VEAT notice is in accordance with the Norwegian Public Procurement Regulation § 21-5 jfr. § 13-4. The contract will be entered into at the earliest 10 days after the publication date of this notice. 1900000.00 Upgrade for Pristina platform for screening machine * 2 Upgrade for Senolris work stations * 3 Helse Bergen intends to procure 2 mammography screening apparatuses and 3 associated work stations from GE Healthcare Norge AS (‘GE’). The procured apparatuses are partial replacements for equipment procured from GE in a former regular procurement process (MTU/2014/PROJECT 000727/Mammografiapparatur for the Breast Diagnostic Center in Bergen). The need for the replacements is caused by the tomosynthesis-study conducted by Helse Bergen (the TOBE-study), which is based on GE screening apparatuses. The study is technically dependent on further use of GE products. The contract is dependant on the funding from the Cancer Association/Research Council of Norway for the continuation of the study. The need for the replacements are the ergonomical weaknesses of the existing machines, which has led to health issues among the users due to the extensive use of the machines in relation to the TOBE-study. Helse Bergen is procuring mammography equipment using digital breast tomosynthesis (DBT) to display synthetic mammograms. The equipment will be utilised in the continuation of the tomosynthesis-study conducted by Helse Bergen (the TOBE research study), which is based on GE screening apparatuses. To continue the study it is necessary to use GE screening apparatuses, as identical pipe- and detector technology is a prerequisite to obtaining relevant research data relevant. The contract contains a reservation regarding the funding for the study by the Cancer Association Research Council of Norway. The need for the replacement screening machines are the ergonomic weaknesses of the existing machines, which has led to health issues among the users due to the extensive use of the machines in relation to the TOBE-study. It is not defensible to continue the study using the existing machines. There are several grounds that legitimises that the contract is entered into without a competitive procedure. In the existing contract with GE, which was part of the procurement documents in the procedure that led to procurement of the existing screening apparatuses, it is stated that additional deliveries can be ordered from Helse Bergen. In any case, Helse Bergen considers the amendment of the contract to include the new equipment to be a lawful and immaterial change of the existing contract. In addition, Helse Bergen considers that these additional deliveries by the original supplier which are intended either as a partial replacement of existing supplies is legal under the Norwegian Procurement Regulation § 13-4 (c), as a change of supplier would make continuation of the TOBE-research study impossible. 2017-09-05 GE Healthcare Norge AS 926293621 Postboks 4574 Nydalen, Vitaminveien 1 Oslo 0485 1900000.00 Helse Bergen HF Bergen 2017-09-05
See tender at TED: http://ted.europa.eu/udl?uri=TED:NOTICE:353563-2017:TEXT:EN:HTML